APO RESEARCH · REPORT
Montelukast Sodium
Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.
Product & engineering
Understand the product.
Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.
Selected research
Market Structure
Global Montelukast Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.
The global montelukast sodium sale market was led by USA, India, Europe and China, where the USA and India are important sales market. At present, there are some manufacturers in every region and the major manufacturers’ activities of montelukast sodium are Morepen Laboratories, Mylan, TAPI, MSN Laboratories, Ultratech India, Aurobindo Pharma, etc. Morepen Laboratories is the globe sales leader, holding 22% sales share in global.
The report provides an overview of the global Montelukast Sodium market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Montelukast Sodium and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Montelukast Sodium sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Montelukast Sodium market size, projected growth trends, production technologies, key applications, and end-use industries.
Montelukast Sodium Segment by Company
Morepen Laboratories
Mylan
TAPI
MSN Laboratories
Ultratech India
Aurobindo Pharma
Hetero Labs
Unimark Remedies
Jubilant Cadista
Aamorb Pharmaceuticals
Sudarshan Group
Ortin Laboratories
Vamsi Labs
Adley Group
Medopharm
Hengyuan Pharmaceutical
Arromax Pharmaceutical Technology
Lihe Wuhan New Chemical Materials
Shanghai Huachu Chemical
Montelukast Sodium Segment by Type
Montelukast Sodium Amorphous
Montelukast Sodium Crystalline
Montelukast Sodium Segment by Application
Tablets
Chewable Tablet
Oral Solution
Montelukast Sodium Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Montelukast Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Montelukast Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Montelukast Sodium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Montelukast Sodium market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Montelukast Sodium industry.
Chapter 3: Detailed analysis of Montelukast Sodium market competition landscape. Including Montelukast Sodium manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Montelukast Sodium by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Montelukast Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Montelukast Sodium Amorphous
- Montelukast Sodium Crystalline
Applications
- Tablets
- Chewable Tablet
- Oral Solution
Companies covered
- Morepen Laboratories
- Mylan
- TAPI
- MSN Laboratories
- Ultratech India
- Aurobindo Pharma
- Hetero Labs
- Unimark Remedies
- Jubilant Cadista
- Aamorb Pharmaceuticals
- Sudarshan Group
- Ortin Laboratories
- Vamsi Labs
- Adley Group
- Medopharm
- Hengyuan Pharmaceutical
- Arromax Pharmaceutical Technology
- Lihe Wuhan New Chemical Materials
- Shanghai Huachu Chemical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Montelukast Sodium Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Montelukast Sodium Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Montelukast Sodium Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Montelukast Sodium Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Montelukast Sodium Market Dynamics
- 2.1 Montelukast Sodium Industry Trends
- 2.2 Montelukast Sodium Industry Drivers
- 2.3 Montelukast Sodium Industry Opportunities and Challenges
- 2.4 Montelukast Sodium Industry Restraints
3 Montelukast Sodium Market by Manufacturers
- 3.1 Global Montelukast Sodium Production Value by Manufacturers (2021-2026)
- 3.2 Global Montelukast Sodium Production by Manufacturers (2021-2026)
- 3.3 Global Montelukast Sodium Average Price by Manufacturers (2021-2026)
- 3.4 Global Montelukast Sodium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Montelukast Sodium Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Montelukast Sodium Manufacturers, Product Type & Application
- 3.7 Global Montelukast Sodium Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Montelukast Sodium Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Montelukast Sodium Players Market Share by Production Value in 2025
- 3.8.3 2025 Montelukast Sodium Tier 1, Tier 2, and Tier 3
4 Montelukast Sodium Market by Type
- 4.1 Montelukast Sodium Type Introduction
- 4.1.1 Montelukast Sodium Amorphous
- 4.1.2 Montelukast Sodium Crystalline
- 4.2 Global Montelukast Sodium Production by Type
- 4.2.1 Global Montelukast Sodium Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Montelukast Sodium Production by Type (2021-2032)
- 4.2.3 Global Montelukast Sodium Production Market Share by Type (2021-2032)
- 4.3 Global Montelukast Sodium Production Value by Type
- 4.3.1 Global Montelukast Sodium Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Montelukast Sodium Production Value by Type (2021-2032)
- 4.3.3 Global Montelukast Sodium Production Value Market Share by Type (2021-2032)
5 Montelukast Sodium Market by Application
- 5.1 Montelukast Sodium Application Introduction
- 5.1.1 Tablets
- 5.1.2 Chewable Tablet
- 5.1.3 Oral Solution
- 5.2 Global Montelukast Sodium Production by Application
- 5.2.1 Global Montelukast Sodium Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Montelukast Sodium Production by Application (2021-2032)
- 5.2.3 Global Montelukast Sodium Production Market Share by Application (2021-2032)
- 5.3 Global Montelukast Sodium Production Value by Application
- 5.3.1 Global Montelukast Sodium Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Montelukast Sodium Production Value by Application (2021-2032)
- 5.3.3 Global Montelukast Sodium Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Morepen Laboratories
- 6.1.1 Morepen Laboratories Company Information
- 6.1.2 Morepen Laboratories Business Overview
- 6.1.3 Morepen Laboratories Montelukast Sodium Production, Value and Gross Margin (2021-2026)
- 6.1.4 Morepen Laboratories Montelukast Sodium Product Portfolio
- 6.1.5 Morepen Laboratories Recent Developments
- 6.2 Mylan
- 6.2.1 Mylan Company Information
- 6.2.2 Mylan Business Overview
- 6.2.3 Mylan Montelukast Sodium Production, Value and Gross Margin (2021-2026)
- 6.2.4 Mylan Montelukast Sodium Product Portfolio
- 6.2.5 Mylan Recent Developments
- 6.3 TAPI
- 6.3.1 TAPI Company Information
- 6.3.2 TAPI Business Overview
- 6.3.3 TAPI Montelukast Sodium Production, Value and Gross Margin (2021-2026)
- 6.3.4 TAPI Montelukast Sodium Product Portfolio
- 6.3.5 TAPI Recent Developments
- 6.4 MSN Laboratories
- 6.4.1 MSN Laboratories Company Information
- 6.4.2 MSN Laboratories Business Overview
- 6.4.3 MSN Laboratories Montelukast Sodium Production, Value and Gross Margin (2021-2026)
- 6.4.4 MSN Laboratories Montelukast Sodium Product Portfolio
- 6.4.5 MSN Laboratories Recent Developments
- 6.5 Ultratech India
- 6.5.1 Ultratech India Company Information
- 6.5.2 Ultratech India Business Overview
- 6.5.3 Ultratech India Montelukast Sodium Production, Value and Gross Margin (2021-2026)
- 6.5.4 Ultratech India Montelukast Sodium Product Portfolio
- 6.5.5 Ultratech India Recent Developments
- 6.6 Aurobindo Pharma
- 6.6.1 Aurobindo Pharma Company Information
- 6.6.2 Aurobindo Pharma Business Overview
- 6.6.3 Aurobindo Pharma Montelukast Sodium Production, Value and Gross Margin (2021-2026)
- 6.6.4 Aurobindo Pharma Montelukast Sodium Product Portfolio
- 6.6.5 Aurobindo Pharma Recent Developments
- 6.7 Hetero Labs
- 6.7.1 Hetero Labs Company Information
- 6.7.2 Hetero Labs Business Overview
- 6.7.3 Hetero Labs Montelukast Sodium Production, Value and Gross Margin (2021-2026)
- 6.7.4 Hetero Labs Montelukast Sodium Product Portfolio
- 6.7.5 Hetero Labs Recent Developments
- 6.8 Unimark Remedies
- 6.8.1 Unimark Remedies Company Information
- 6.8.2 Unimark Remedies Business Overview
- 6.8.3 Unimark Remedies Montelukast Sodium Production, Value and Gross Margin (2021-2026)
- 6.8.4 Unimark Remedies Montelukast Sodium Product Portfolio
- 6.8.5 Unimark Remedies Recent Developments
- 6.9 Jubilant Cadista
- 6.9.1 Jubilant Cadista Company Information
- 6.9.2 Jubilant Cadista Business Overview
- 6.9.3 Jubilant Cadista Montelukast Sodium Production, Value and Gross Margin (2021-2026)
- 6.9.4 Jubilant Cadista Montelukast Sodium Product Portfolio
- 6.9.5 Jubilant Cadista Recent Developments
- 6.10 Aamorb Pharmaceuticals
- 6.10.1 Aamorb Pharmaceuticals Company Information
- 6.10.2 Aamorb Pharmaceuticals Business Overview
- 6.10.3 Aamorb Pharmaceuticals Montelukast Sodium Production, Value and Gross Margin (2021-2026)
- 6.10.4 Aamorb Pharmaceuticals Montelukast Sodium Product Portfolio
- 6.10.5 Aamorb Pharmaceuticals Recent Developments
- 6.11 Sudarshan Group
- 6.11.1 Sudarshan Group Company Information
- 6.11.2 Sudarshan Group Business Overview
- 6.11.3 Sudarshan Group Montelukast Sodium Production, Value and Gross Margin (2021-2026)
- 6.11.4 Sudarshan Group Montelukast Sodium Product Portfolio
- 6.11.5 Sudarshan Group Recent Developments
- 6.12 Ortin Laboratories
- 6.12.1 Ortin Laboratories Company Information
- 6.12.2 Ortin Laboratories Business Overview
- 6.12.3 Ortin Laboratories Montelukast Sodium Production, Value and Gross Margin (2021-2026)
- 6.12.4 Ortin Laboratories Montelukast Sodium Product Portfolio
- 6.12.5 Ortin Laboratories Recent Developments
- 6.13 Vamsi Labs
- 6.13.1 Vamsi Labs Company Information
- 6.13.2 Vamsi Labs Business Overview
- 6.13.3 Vamsi Labs Montelukast Sodium Production, Value and Gross Margin (2021-2026)
- 6.13.4 Vamsi Labs Montelukast Sodium Product Portfolio
- 6.13.5 Vamsi Labs Recent Developments
- 6.14 Adley Group
- 6.14.1 Adley Group Company Information
- 6.14.2 Adley Group Business Overview
- 6.14.3 Adley Group Montelukast Sodium Production, Value and Gross Margin (2021-2026)
- 6.14.4 Adley Group Montelukast Sodium Product Portfolio
- 6.14.5 Adley Group Recent Developments
- 6.15 Medopharm
- 6.15.1 Medopharm Company Information
- 6.15.2 Medopharm Business Overview
- 6.15.3 Medopharm Montelukast Sodium Production, Value and Gross Margin (2021-2026)
- 6.15.4 Medopharm Montelukast Sodium Product Portfolio
- 6.15.5 Medopharm Recent Developments
- 6.16 Hengyuan Pharmaceutical
- 6.16.1 Hengyuan Pharmaceutical Company Information
- 6.16.2 Hengyuan Pharmaceutical Business Overview
- 6.16.3 Hengyuan Pharmaceutical Montelukast Sodium Production, Value and Gross Margin (2021-2026)
- 6.16.4 Hengyuan Pharmaceutical Montelukast Sodium Product Portfolio
- 6.16.5 Hengyuan Pharmaceutical Recent Developments
- 6.17 Arromax Pharmaceutical Technology
- 6.17.1 Arromax Pharmaceutical Technology Company Information
- 6.17.2 Arromax Pharmaceutical Technology Business Overview
- 6.17.3 Arromax Pharmaceutical Technology Montelukast Sodium Production, Value and Gross Margin (2021-2026)
- 6.17.4 Arromax Pharmaceutical Technology Montelukast Sodium Product Portfolio
- 6.17.5 Arromax Pharmaceutical Technology Recent Developments
- 6.18 Lihe Wuhan New Chemical Materials
- 6.18.1 Lihe Wuhan New Chemical Materials Company Information
- 6.18.2 Lihe Wuhan New Chemical Materials Business Overview
- 6.18.3 Lihe Wuhan New Chemical Materials Montelukast Sodium Production, Value and Gross Margin (2021-2026)
- 6.18.4 Lihe Wuhan New Chemical Materials Montelukast Sodium Product Portfolio
- 6.18.5 Lihe Wuhan New Chemical Materials Recent Developments
- 6.19 Shanghai Huachu Chemical
- 6.19.1 Shanghai Huachu Chemical Company Information
- 6.19.2 Shanghai Huachu Chemical Business Overview
- 6.19.3 Shanghai Huachu Chemical Montelukast Sodium Production, Value and Gross Margin (2021-2026)
- 6.19.4 Shanghai Huachu Chemical Montelukast Sodium Product Portfolio
- 6.19.5 Shanghai Huachu Chemical Recent Developments
7 Global Montelukast Sodium Production by Region
- 7.1 Global Montelukast Sodium Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Montelukast Sodium Production by Region (2021-2032)
- 7.2.1 Global Montelukast Sodium Production by Region (2021-2026)
- 7.2.2 Global Montelukast Sodium Production Forecast by Region (2027-2032)
- 7.3 Global Montelukast Sodium Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Montelukast Sodium Production Value by Region (2021-2032)
- 7.4.1 Global Montelukast Sodium Production Value by Region (2021-2026)
- 7.4.2 Global Montelukast Sodium Production Value by Region (2027-2032)
- 7.5 Global Montelukast Sodium Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Montelukast Sodium Production Value (2021-2032)
- 7.6.2 Europe Montelukast Sodium Production Value (2021-2032)
- 7.6.3 Asia-Pacific Montelukast Sodium Production Value (2021-2032)
- 7.6.4 South America Montelukast Sodium Production Value (2021-2032)
- 7.6.5 Middle East & Africa Montelukast Sodium Production Value (2021-2032)
8 Global Montelukast Sodium Consumption by Region
- 8.1 Global Montelukast Sodium Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Montelukast Sodium Consumption by Region (2021-2032)
- 8.2.1 Global Montelukast Sodium Consumption by Region (2021-2026)
- 8.2.2 Global Montelukast Sodium Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Montelukast Sodium Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Montelukast Sodium Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Montelukast Sodium Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Montelukast Sodium Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Montelukast Sodium Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Montelukast Sodium Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Montelukast Sodium Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Montelukast Sodium Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Montelukast Sodium Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Montelukast Sodium Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Montelukast Sodium Value Chain Analysis
- 9.1.1 Montelukast Sodium Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Montelukast Sodium Production Mode & Process
- 9.2 Montelukast Sodium Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Montelukast Sodium Distributors
- 9.2.3 Montelukast Sodium Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst